US Stock MarketDetailed Quotes

Candel Therapeutics (CADL)

Watchlist
  • 6.300
  • 0.0000.00%
Close Jan 22 16:00 ET
  • 6.300
  • 0.0000.00%
Post 20:01 ET
345.86MMarket Cap-11.25P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Candel Therapeutics (CADL) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
50.82%13.21M
30.40%11.18M
2.89%8.13M
-13.08%33.37M
-21.37%8.14M
-1.04%8.76M
-10.41%8.57M
-17.87%7.9M
10.32%38.39M
28.08%10.35M
Selling and administrative expenses
42.05%4.75M
16.54%4.19M
8.26%4.11M
1.24%14.06M
8.63%3.32M
10.78%3.34M
-1.45%3.59M
-8.74%3.8M
-1.24%13.89M
-3.16%3.06M
-General and administrative expense
42.05%4.75M
16.54%4.19M
8.26%4.11M
1.24%14.06M
8.63%3.32M
10.78%3.34M
-1.45%3.59M
-8.74%3.8M
-1.24%13.89M
-3.16%3.06M
Research and development costs
56.22%8.46M
40.41%6.99M
-2.10%4.02M
-21.19%19.31M
-33.63%4.82M
-7.34%5.42M
-16.09%4.98M
-25.00%4.1M
17.89%24.51M
45.98%7.26M
Operating profit
-50.82%-13.21M
-30.40%-11.18M
-2.89%-8.13M
13.08%-33.37M
21.37%-8.14M
1.04%-8.76M
10.41%-8.57M
17.87%-7.9M
-10.72%-38.39M
-28.57%-10.35M
Net non-operating interest income expense
415.54%792K
311.01%690K
292.64%628K
-95.33%-1M
61.24%-100K
-50.30%-251K
-71.20%-327K
-419.61%-326K
-4.90%-514K
-214.16%-258K
Non-operating interest income
303.81%953K
285.83%926K
191.88%934K
-47.81%1.09M
-30.12%290K
-52.99%236K
-47.02%240K
-54.99%320K
70.85%2.08M
-48.38%415K
Non-operating interest expense
-66.94%161K
-58.38%236K
-52.63%306K
-19.46%2.09M
-42.05%390K
-27.20%487K
-11.96%567K
6.08%646K
51.93%2.6M
16.44%673K
Other net income (expense)
169.96%1.15M
142.66%5.69M
212,485.71%14.88M
-2,253.42%-20.8M
-1,107.45%-5.83M
-381.93%-1.64M
-9,363.19%-13.34M
-99.03%7K
-94.10%966K
-117.60%-483K
Gain on sale of security
169.96%1.15M
142.66%5.69M
212,485.71%14.88M
-2,253.42%-20.8M
-1,107.45%-5.83M
-381.93%-1.64M
-9,363.19%-13.34M
-99.03%7K
-94.10%966K
-117.60%-483K
Income before tax
-5.85%-11.27M
78.43%-4.8M
189.76%7.38M
-45.44%-55.18M
-26.84%-14.07M
-26.21%-10.65M
-131.30%-22.24M
6.53%-8.22M
-101.87%-37.94M
-118.28%-11.1M
Income tax
Net income
-5.85%-11.27M
78.43%-4.8M
189.76%7.38M
-45.44%-55.18M
-26.84%-14.07M
-26.21%-10.65M
-131.30%-22.24M
6.53%-8.22M
-101.87%-37.94M
-118.28%-11.1M
Net income continuous Operations
-5.85%-11.27M
78.43%-4.8M
189.76%7.38M
-45.44%-55.18M
-26.84%-14.07M
-26.21%-10.65M
-131.30%-22.24M
6.53%-8.22M
-101.87%-37.94M
-118.28%-11.1M
Minority interest income
Net income attributable to the parent company
-5.85%-11.27M
78.43%-4.8M
189.76%7.38M
-45.44%-55.18M
-26.84%-14.07M
-26.21%-10.65M
-131.30%-22.24M
6.53%-8.22M
-101.87%-37.94M
-118.28%-11.1M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-5.85%-11.27M
78.43%-4.8M
189.76%7.38M
-45.44%-55.18M
-26.84%-14.07M
-26.21%-10.65M
-131.30%-22.24M
6.53%-8.22M
-101.87%-37.94M
-118.28%-11.1M
Basic earnings per share
36.36%-0.21
87.84%-0.09
153.57%0.15
-32.82%-1.74
-5.26%-0.4
-13.79%-0.33
-124.24%-0.74
6.67%-0.28
-101.54%-1.31
-111.11%-0.38
Diluted earnings per share
36.36%-0.21
87.84%-0.09
146.43%0.13
-32.82%-1.74
-5.26%-0.4
-13.79%-0.33
-124.24%-0.74
6.67%-0.28
-101.54%-1.31
-111.11%-0.38
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 50.82%13.21M30.40%11.18M2.89%8.13M-13.08%33.37M-21.37%8.14M-1.04%8.76M-10.41%8.57M-17.87%7.9M10.32%38.39M28.08%10.35M
Selling and administrative expenses 42.05%4.75M16.54%4.19M8.26%4.11M1.24%14.06M8.63%3.32M10.78%3.34M-1.45%3.59M-8.74%3.8M-1.24%13.89M-3.16%3.06M
-General and administrative expense 42.05%4.75M16.54%4.19M8.26%4.11M1.24%14.06M8.63%3.32M10.78%3.34M-1.45%3.59M-8.74%3.8M-1.24%13.89M-3.16%3.06M
Research and development costs 56.22%8.46M40.41%6.99M-2.10%4.02M-21.19%19.31M-33.63%4.82M-7.34%5.42M-16.09%4.98M-25.00%4.1M17.89%24.51M45.98%7.26M
Operating profit -50.82%-13.21M-30.40%-11.18M-2.89%-8.13M13.08%-33.37M21.37%-8.14M1.04%-8.76M10.41%-8.57M17.87%-7.9M-10.72%-38.39M-28.57%-10.35M
Net non-operating interest income expense 415.54%792K311.01%690K292.64%628K-95.33%-1M61.24%-100K-50.30%-251K-71.20%-327K-419.61%-326K-4.90%-514K-214.16%-258K
Non-operating interest income 303.81%953K285.83%926K191.88%934K-47.81%1.09M-30.12%290K-52.99%236K-47.02%240K-54.99%320K70.85%2.08M-48.38%415K
Non-operating interest expense -66.94%161K-58.38%236K-52.63%306K-19.46%2.09M-42.05%390K-27.20%487K-11.96%567K6.08%646K51.93%2.6M16.44%673K
Other net income (expense) 169.96%1.15M142.66%5.69M212,485.71%14.88M-2,253.42%-20.8M-1,107.45%-5.83M-381.93%-1.64M-9,363.19%-13.34M-99.03%7K-94.10%966K-117.60%-483K
Gain on sale of security 169.96%1.15M142.66%5.69M212,485.71%14.88M-2,253.42%-20.8M-1,107.45%-5.83M-381.93%-1.64M-9,363.19%-13.34M-99.03%7K-94.10%966K-117.60%-483K
Income before tax -5.85%-11.27M78.43%-4.8M189.76%7.38M-45.44%-55.18M-26.84%-14.07M-26.21%-10.65M-131.30%-22.24M6.53%-8.22M-101.87%-37.94M-118.28%-11.1M
Income tax
Net income -5.85%-11.27M78.43%-4.8M189.76%7.38M-45.44%-55.18M-26.84%-14.07M-26.21%-10.65M-131.30%-22.24M6.53%-8.22M-101.87%-37.94M-118.28%-11.1M
Net income continuous Operations -5.85%-11.27M78.43%-4.8M189.76%7.38M-45.44%-55.18M-26.84%-14.07M-26.21%-10.65M-131.30%-22.24M6.53%-8.22M-101.87%-37.94M-118.28%-11.1M
Minority interest income
Net income attributable to the parent company -5.85%-11.27M78.43%-4.8M189.76%7.38M-45.44%-55.18M-26.84%-14.07M-26.21%-10.65M-131.30%-22.24M6.53%-8.22M-101.87%-37.94M-118.28%-11.1M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -5.85%-11.27M78.43%-4.8M189.76%7.38M-45.44%-55.18M-26.84%-14.07M-26.21%-10.65M-131.30%-22.24M6.53%-8.22M-101.87%-37.94M-118.28%-11.1M
Basic earnings per share 36.36%-0.2187.84%-0.09153.57%0.15-32.82%-1.74-5.26%-0.4-13.79%-0.33-124.24%-0.746.67%-0.28-101.54%-1.31-111.11%-0.38
Diluted earnings per share 36.36%-0.2187.84%-0.09146.43%0.13-32.82%-1.74-5.26%-0.4-13.79%-0.33-124.24%-0.746.67%-0.28-101.54%-1.31-111.11%-0.38
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.65%
Sample Name
Sample Code
 +4.15%
Sample Name
Sample Code
 +2.94%
4
Clean Energy Fuels
CLNE
+2.70%
5
American Express
AXP
+2.34%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +24.00%
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +7.44%
4
KE Holdings
BEKE
+5.08%
5
NIO Inc
NIO
+4.61%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -